Dong Bang Co Ltd Strengthens Global Competitiveness with Advanced Veterinary Pharmaceuticals
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dong Bang Co Ltd is strengthening its position in the global veterinary pharmaceutical market with high-value products including pet anesthetics and livestock reproductive hormones. Since its...
Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026
Oral presentation of DZD6008 demonstrated strong and durable anti-tumor activity, excellent BBB-penetrant properties, and a favorable safety profile in patients relapsed from third-generation EGFR TKI In treatment-naive patients with advanced NSCLC...
Makuake Hit Product UWANT Flagship V800 Vacuum Officially Launches on Amazon Japan
TOKYO, May 22, 2026 /PRNewswire/ -- UWANT, a professional brand focused on cleaning appliances, has officially launched its flagship anti-hair tangle self-emptying vacuum cleaner "UWANT V800" on Amazon Japan following its breakout success on...
Phase II Data from a Randomized Double-Blind Trial of Ligufalimab (Anti-CD47) Combination Therapy in Frontline AML Published at EHA 2026
HONG KONG, May 15, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will be...
ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies
TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing...
Copyright Enforcement Dialogue 2026 in Taipei Reinforces Regional Public-Private Cooperation Against Digital Piracy
TAIPEI, April 23, 2026 /PRNewswire/ -- On April 22, 2026, the Motion Picture Association (MPA) Asia Pacific concluded the Copyright Enforcement Dialogue: Taipei 2026, convening senior policymakers, law enforcement authorities, judicial...
Hengrui Pharma Reports Q1 2026 Results with Revenue and Net Profit Growth
SHANGHAI, April 22, 2026 /PRNewswire/ -- Hengrui Pharma reported steady growth in the first quarter of 2026. In Q1 2026, the Company recorded revenue of RMB 8.14 billion, up 12.98% year-over-year, while net profit attributable to shareholders...
Xinhua Silk Road: Traceability & anti-counterfeiting help ensure reliable quality of green tea in Rizhao
BEIJING, April 14, 2026 /PRNewswire/ -- In Rizhao, one of the world's three major coastal green tea cities, a complete tea industry chain traceability and anti-counterfeiting system is helping the eastern China locality ensure superb quality of...
VEVOR and Rebuilding Together Houston Restore a Legacy Home, One Solution at a Time
HOUSTON, April 3, 2026 /PRNewswire/ -- For Regina Walker, a breast cancer survivor in Houston's South Union community, her 75-year-old legacy home represents three generations of family memories. However, time and financial hardship had taken a...
Earendil Labs Announces First Patient Dosed in a Phase IIa Trial of a Half-life Extended Anti-TL1A Antibody (HXN-1001) in Patients with Ulcerative Colitis
WILMINGTON, Del., April 2, 2026 /PRNewswire/ -- Earendil Labs, an AI-driven biotechnology company advancing next-generation biologics, today announced the first patient has been dosed in a Phase IIa clinical trial of HXN-1001, a half-life extended...